C9ORF72-derived polyGR polypeptides disrupt passive nucleocytoplasmic transport by tuning protein affinity for the nuclear pore barrier

This study reveals that C9ORF72-derived polyGR polypeptides disrupt nucleocytoplasmic transport in ALS/FTD by non-linearly retuning the nuclear pore's selectivity barrier, causing a biphasic modulation where proteins with moderate hydrophobicity exhibit enhanced transport while highly hydrophobic proteins are suppressed and accumulate in the cytoplasm.

The Gist

The Big Picture: A Broken Gatekeeper in the Brain

Imagine your cell as a busy city. Inside this city, there is a very important building called the Nucleus (the city hall), where the blueprints for the city (DNA) are kept safe. To get in and out of city hall, there is a massive, high-tech security gate called the Nuclear Pore Complex.

This gate is very picky. It has a special "foggy" barrier made of tangled, sticky strings (called FG-nucleoporins).

• Small, innocent people (tiny molecules) can walk right through the fog.
• Important VIPs (proteins with special ID badges) have a key that lets them slip through the sticky strings easily.
• Random strangers (big, sticky proteins without a badge) usually get stuck or bounce off.

In a disease called ALS/FTD (a type of motor neuron disease), a genetic glitch creates a toxic "garbage" protein called polyGR. This paper discovers exactly how this garbage protein breaks the security gate, causing chaos in the city.

---

The Discovery: The "Grease" That Goes Wrong

The researchers found that the toxic polyGR protein doesn't just block the gate like a boulder in a doorway. Instead, it acts like a mischievous gremlin that climbs onto the sticky strings of the gate and changes how they feel to other people.

Here is the surprising part: PolyGR changes the rules of the gate based on how "sticky" a protein is.

1. The "Non-Sticky" People (FG-Phobic)

Imagine a person wearing a smooth, Teflon-coated suit. They don't stick to anything.

• What happens: When polyGR shows up, these people are unaffected. They still can't get through the gate easily, but they don't get stuck either. They just keep doing what they were doing.

2. The "Moderately Sticky" People (FG-Philic)

Imagine a person wearing a slightly fuzzy sweater. They have a little bit of stickiness.

• What happens: Normally, they might struggle to get through the gate. But when polyGR arrives, it acts like a molecular lubricant. It grabs the fuzzy sweater and helps pull the person through the sticky fog.
• Result: These proteins get into the nucleus faster than usual. The gate is working too well for them.

3. The "Super-Sticky" People (Highly Hydrophobic)

Imagine a person covered in super-glue or heavy tar. They are incredibly sticky.

• What happens: This is where things go wrong. PolyGR loves to stick to these super-sticky people. Instead of helping them through the gate, polyGR grabs them and forms a giant, sticky clump outside the gate.
• Result: These proteins get stuck in the cytoplasm (the city streets), they can't get into city hall, and they start forming toxic piles (aggregates). This is a major cause of cell death in ALS.

The "Biphasic" Effect (The Goldilocks Zone)

The paper calls this a "biphasic" effect. Think of it like a volume knob on a radio:

• Turn it up a little (moderate stickiness): The sound gets better (transport improves).
• Turn it up too much (high stickiness): The speaker blows out, and the sound cuts out completely (transport stops, and things clump together).

PolyGR turns the "stickiness knob" on the nuclear gate. It helps the moderately sticky proteins get in, but it traps the super-sticky ones outside.

Why Does This Matter?

The most famous victim of this problem is a protein called TDP-43. In ALS patients, TDP-43 is found in the wrong place (the cytoplasm) instead of the nucleus, where it forms toxic clumps.

This paper explains why TDP-43 is so vulnerable:

1. TDP-43 is naturally "sticky" (it has hydrophobic patches).
2. Because it is sticky, polyGR grabs onto it.
3. Instead of helping TDP-43 get into the nucleus, polyGR drags it down, causing it to clump up outside.

The Takeaway

The researchers didn't just look at the size of the proteins; they looked at their surface chemistry (how sticky they are). They proved that the toxic polyGR protein rewrites the physical rules of the nuclear gate.

• Before: The gate was a selective filter based on size and ID badges.
• After PolyGR: The gate becomes a chaotic mixer that helps some proteins in but traps others in toxic piles, depending entirely on how "sticky" their surface is.

This discovery gives scientists a new way to think about treating ALS: maybe we can design drugs that stop polyGR from grabbing onto these sticky proteins, or we can change the "stickiness" of the proteins so they don't get caught in the trap.

Technical Summary

1. Problem Statement

Nucleocytoplasmic transport is essential for cellular homeostasis, governed by the Nuclear Pore Complex (NPC). The NPC's permeability barrier consists of intrinsically disordered, phenylalanine-glycine (FG) repeat-rich nucleoporins (FG Nups) that form a selective "FG phase." Disruption of this transport is a hallmark of neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).

The most common genetic cause of ALS/FTD is a G4C2 repeat expansion in the C9ORF72 gene, which produces aberrant dipeptide repeat proteins (DPRs), notably polyGR and polyPR. While these DPRs are known to cause nucleocytoplasmic transport defects and the cytoplasmic mislocalization of TDP-43, the biophysical mechanism by which they disrupt transport remains unclear. Specifically, it is unknown why some proteins mislocalize while others do not, and whether this is driven by protein size or specific surface chemistry.

2. Methodology

The authors employed a multi-modal approach combining in silico simulations, in vitro reconstitution, and cellular assays to dissect the interaction between polyGR and the NPC barrier.

• Coarse-Grained Simulations: Using the PIMMS simulation engine, the authors modeled the Nup98 FG domain condensate. They simulated various 10-mer dipeptide repeat probes and client proteins in the presence and absence of polyGR to map interaction strengths and partitioning behaviors based on amino acid composition.
• In Vitro FG Phase Reconstitution: Recombinant human Nup98 FG domains (residues 1–499) were purified and induced to phase-separate into condensates. These served as a model for the NPC permeability barrier.
  • Variants: Nup98 FG variants (F>Y, F>L, F>S) were created to test the role of aromatic vs. hydrophobic interactions.
  • Clients: A panel of fluorescent proteins (EGFP, mCherry) and a systematic series of efGFP surface mutants (designed to vary surface hydrophobicity and FG-affinity without altering size or structure) were used to test partitioning.
• Cellular Assays:
  • HeLa Cells: Semi-permeabilized cells were used for live-cell nuclear import assays with fluorescent dextrans and GFP variants, with and without polyGR treatment.
  • iPSC-Derived Neurons: Human induced pluripotent stem cells (KOLF2.1J) were differentiated into cortical neurons to validate findings in a disease-relevant neuronal context.
  • Super-Resolution Microscopy: Two-color STORM (Stochastic Optical Reconstruction Microscopy) combined with DNA-PAINT was used in U2OS cells to visualize the precise localization of polyGR relative to the NPC scaffold (Nup96).

3. Key Contributions

• Mechanism of Disruption: The paper establishes that polyGR does not simply block the nuclear pore or uniformly loosen the FG barrier. Instead, it retunes the physicochemical selectivity of the FG phase.
• Surface Chemistry Dependence: The study demonstrates that the impact of polyGR is dictated by the surface chemistry (specifically solvent-exposed hydrophobic and aromatic residues) of client proteins, rather than their molecular weight.
• Biphasic Response Model: The authors define a biphasic continuum of transport outcomes:
  1. FG-Phobic Proteins: Unaffected by polyGR.
  2. Moderately FG-Philic Proteins: Exhibit enhanced nuclear import.
  3. Highly FG-Philic/Hydrophobic Proteins: Experience transport suppression, cytoplasmic accumulation, and aggregation.
• Direct Binding Evidence: The study provides direct evidence that polyGR binds within the central channel of the NPC in human cells, engaging the FG-rich barrier.

4. Key Results

• PolyGR Selectively Enhances Transport of Specific Clients:

  • In HeLa cells and Nup98 condensates, polyGR significantly increased the nuclear import of EGFP (which has moderate FG-affinity) but had no effect on mCherry (which is FG-phobic), despite their similar sizes (~27–29 kDa).
  • This selectivity was confirmed using the efGFP mutant series:
    • FG-phobic variants (e.g., efGFP_8K, sinGFP4a) showed no change in transport.
    • FG-philic variants (e.g., efGFP_8A, efGFP_3W) showed markedly enhanced nuclear import.
    • Highly hydrophobic variants (e.g., efGFP_8L, efGFP_8W) showed a reduction in nuclear import and formed cytoplasmic aggregates.

• Role of Aromatic and Hydrophobic Interactions:

  • In Vitro: PolyGR partitioned strongly into wild-type Nup98 condensates and F>Y (aromatic-preserving) variants but weakly into F>L and F>S variants. This indicates polyGR engagement relies heavily on aromatic interactions (likely cation-$\pi$ between arginine and phenylalanine) and hydrophobicity.
  • Simulations: Coarse-grained simulations revealed that polyGR acts as a "molecular lubricant" for moderately hydrophobic clients, increasing their local concentration in the FG phase. However, for highly hydrophobic clients, polyGR promotes co-assembly outside the condensate (aggregation) or sequesters them, preventing entry.

• Validation in Neurons:

  • The biphasic effect was recapitulated in human iPSC-derived cortical neurons. PolyGR enhanced import of wild-type efGFP and FG-philic variants but caused cytoplasmic aggregation of the highly hydrophobic efGFP_8W variant.

• Super-Resolution Imaging:

  • STORM imaging confirmed that ATTO655-labeled polyGR localizes to the central channel of the NPC in human cells, distinct from the structural scaffold (Nup96), confirming direct interaction with the FG barrier in a native environment.

5. Significance

• Explaining Selective Vulnerability: This work provides a biophysical explanation for why specific proteins (like TDP-43) are selectively vulnerable to mislocalization in C9ORF72-ALS/FTD. TDP-43 contains hydrophobic regions that make it FG-philic; polyGR likely exacerbates its passive export or promotes cytoplasmic aggregation by shifting the FG phase chemistry.
• Redefining Transport Defects: The findings challenge the view that nuclear pore dysfunction is a simple "clogging" or "leakage" event. Instead, it is a chemically encoded reprogramming of transport rules where the "selectivity filter" is altered by the disease-associated peptide.
• Therapeutic Implications: Understanding that transport disruption is driven by specific surface chemistry interactions suggests that therapeutic strategies could target the polyGR-FG interaction interface or modulate the surface properties of vulnerable proteins to prevent aggregation and mislocalization.
• General Principle: The study establishes a general framework for how aberrant polypeptides can disrupt biomolecular condensates (like the NPC) by altering the emergent material properties of the phase, a mechanism likely relevant to other neurodegenerative diseases involving phase separation.